14M Genomics Ltd, a cancer diagnostics company, has appointed Alan Schafer as its chief executive officer. Dr Schafer was previously CEO of Population Genetics Technologies Inc in the US where he led that company’s commercialisation strategy for next generation sequencing-based diagnostic products for infectious disease. Prior to that, he was director of science funding for the Wellcome Trust. 14M Genomics was founded in 2014 by senior officials at the Wellcome Trust Sanger Institute in Hinxton, UK.
14M Genomics announced the appointment on 14 July 2015.
Copyright 2015 Evernow Publishing Ltd